Evaluation of a New Tandem Mass Spectrometry Method for Sickle Cell Disease Newborn Screening

In France, sickle cell disease newborn screening (SCD NBS) has been targeted to at-risk regions since 1984, but generalization to the whole population will be implemented from November 2024. Although tandem mass spectrometry (MS/MS) is already used for the NBS of several inherited metabolic diseases...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of neonatal screening 2024-11, Vol.10 (4), p.77
Hauptverfasser: Renoux, Céline, Roland, Estelle, Ruet, Séverine, Zouaghi, Sarah, Michel, Marie, Joly, Philippe, Feray, Cécile, Zhao, Fanny, Gavanier, Déborah, Gaucherand, Pascal, Roumieu, Fanny, Cannas, Giovanna, Merazga, Salima, Connes, Philippe, Renom, Gilles, Massardier, Jérôme, Cheillan, David
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!